Prenuvo

Prenuvo is a preventive health company pioneering whole-body MRI scanning for early disease detection. Founded in 2018 in Vancouver, Canada, by CEO Andrew Lacy and radiologist Dr. Raj Attariwala, Prenuvo offers comprehensive, radiation-free MRI scans that screen for hundreds of conditions — including cancers, aneurysms, and organ diseases — often before symptoms appear. The company combines advanced MRI technology with AI-powered analysis and expert radiologists to deliver actionable health insights. Prenuvo has expanded from its Canadian roots to operate scanning clinics across the United States and has attracted investment from notable figures including 23andMe co-founder Anne Wojcicki. As of 2024, Prenuvo has completed over 100,000 scans and raised more than $120M in Series B funding.